154 related articles for article (PubMed ID: 23170140)
1. CASP-8 -652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis.
Chen D; Ma T; Liu XW; Liu Z
Exp Ther Med; 2012 Oct; 4(4):762-770. PubMed ID: 23170140
[TBL] [Abstract][Full Text] [Related]
2. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
3. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
4. Association between CASP-8 gene polymorphisms and cancer risk in some Asian population based on a HuGE review and meta-analysis.
Zhang YJ; Zhong XP; Chen Y; Liu SR; Wu G; Liu YF
Genet Mol Res; 2013 Feb; 12(4):6466-76. PubMed ID: 23479148
[TBL] [Abstract][Full Text] [Related]
5. A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer.
Zhang ZY; Xuan Y; Jin XY; Tian X; Wu R
Genet Mol Res; 2013 Jan; 12(3):3057-69. PubMed ID: 23315881
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.
Du H; Song GX; Fang MZ; Shu YQ; Zhao X; Zhu LJ
J Biomed Res; 2019 Jun; 33(3):173-180. PubMed ID: 30057371
[TBL] [Abstract][Full Text] [Related]
7. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
8. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
9. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
10. CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men.
Fu G; Tang J; Wang M; Qin C; Yan F; Ding Q; Yin C; Wang X; Zhang Z
J Biomed Res; 2011 Mar; 25(2):128-34. PubMed ID: 23554680
[TBL] [Abstract][Full Text] [Related]
11. A six-nucleotide deletion polymorphism in the casp8 promoter is associated with reduced risk of esophageal and gastric cancers in Kashmir valley.
Malik MA; Zargar SA; Mittal B
Indian J Hum Genet; 2011 Sep; 17(3):152-6. PubMed ID: 22345985
[TBL] [Abstract][Full Text] [Related]
12. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
13. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
Li Z; Wang J; Wang F; Ma Z; Yu Z
Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
[TBL] [Abstract][Full Text] [Related]
14. Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer.
Wu Z; Li Y; Li S; Zhu L; Li G; Yu Z; Zhao X; Ge J; Cui B; Dong X; Tian S; Hu F; Zhao Y
Med Oncol; 2013; 30(3):565. PubMed ID: 23715747
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 gene polymorphisms and cancer susceptibility: a meta-analysis.
Wang X; Li J; Xie W; Zhang W; Chang Y
Neoplasma; 2013; 60(4):459-67. PubMed ID: 23581420
[TBL] [Abstract][Full Text] [Related]
17. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
18. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
[TBL] [Abstract][Full Text] [Related]
19. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous Ins/Del genotype of the CASP8 rs3834129 polymorphism significantly decreases the risk of coal workers' pneumoconiosis in a Chinese Han population: a case-control study.
Hou ZF; Wang H; Ji SQ; Kang DM; Zhao H; Guo Y; Ma JF; Wang JZ; Ma X; Gao Y
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7726-7733. PubMed ID: 34982434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]